Cite
Cost-effectiveness analysis of switching from a trivalent to a quadrivalent inactivated influenza vaccine in the Peruvian immunisation programme.
MLA
Bellier, Lucile, et al. “Cost-Effectiveness Analysis of Switching from a Trivalent to a Quadrivalent Inactivated Influenza Vaccine in the Peruvian Immunisation Programme.” Vaccine, vol. 39, no. 30, July 2021, pp. 4144–52. EBSCOhost, https://doi.org/10.1016/j.vaccine.2021.05.084.
APA
Bellier, L., Petitjean, A., Sarazu, T., Tresierra, J., & Lopez, J. G. (2021). Cost-effectiveness analysis of switching from a trivalent to a quadrivalent inactivated influenza vaccine in the Peruvian immunisation programme. Vaccine, 39(30), 4144–4152. https://doi.org/10.1016/j.vaccine.2021.05.084
Chicago
Bellier, Lucile, Audrey Petitjean, Tatiana Sarazu, Julio Tresierra, and Juan Guillermo Lopez. 2021. “Cost-Effectiveness Analysis of Switching from a Trivalent to a Quadrivalent Inactivated Influenza Vaccine in the Peruvian Immunisation Programme.” Vaccine 39 (30): 4144–52. doi:10.1016/j.vaccine.2021.05.084.